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follow-up. Differences in functional response between CSA and
non-CSA patients may only become evident later or in larger
patient cohorts. The studies on posttransplant patients (4,5) had
longer follow-up times but also showed similar improvement in
both CSA and non-CSA patients. The effect of CRT on CSA in our
study seemed larger than in these studies, which may be explained by
the fact that OSA patients were not included and new OSA was not
observed in our patients during CRT. It is yet unclear why OSA
develops in some patients after cardiac transplantation.
Finally, all our patients had ventricular conduction disturbance,
which qualified them for CRT. The incidence of ventricular
conduction disturbance has not been reported in previous trials on
CSA. The association of CSA and cardiac rhythm disturbances
such as atrial fibrillation has recently gained interest (6). We hope
that our data may stimulate further research into this direction.
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Effects of Percutaneous
Left Atrial Appendage
Transcatheter Occlusion (PLAATO)
on Left Atrial Structure and Function
With great interest we read the study by Hanna et al. (1) on left
atrial (LA) structure and function after percutaneous left atrial
appendage transcatheter occlusion (PLAATO). In 11 patients,
adequate seal of the left atrial appendage (LAA) is reported
without affecting LA function or the left upper pulmonary vein.
The PLAATO had first been performed in 25 dogs in sinus
rhythm. This study by Nakai et al. (2) has been the scientific basis
for implanting the device in humans (1,3,4). Although this
technique appears very attractive, there are several points of
criticism concerning study design, data collection, and interpreta-
tion of the results.
1. The LA diameter is reported only at baseline. Furthermore,
peak mitral E-wave velocity and diameter, peak systolic, and
diastolic velocities of the left upper pulmonary vein were not
registered in every patient at baseline, 1, and 6 months.
Overall, only 3 of the 11 patients (cases 1, 2, and 5) had all
measurements completed. Thus, conclusions based on frag-
mentary data in this small patient population are limited.
2. Concerning the importance of the LAA as a hormone-
releasing site, the study lacks information about levels of
natriuretic peptides before and after PLAATO.
3. The investigators state that PLAATO does not interfere with
LA function because there was no significant change in
transmitral or pulmonary venous flow. However, no LA
pressure measurements are reported. Because LAA occlusion
may result in reduced atrial compliance, data on LA diameter
and volume during follow-up would be of interest.
4. Hanna et al. conclude that the PLAATO device does not
result in any detrimental anatomic or physiologic changes to
adjacent structures. Besides left upper pulmonary vein and
mitral valve, however, the circumflex branch of the left
coronary artery lies adjacent to the LAA base. Therefore,
information on the development of anginal chest pain after
PLAATO is of importance.
5. The finding of minimal flow around the PLAATO device in
every patient immediately after implantation and at follow-up
is in contrast to complete LAA occlusion found at necropsy in
dogs of the initial study by Nakai et al. (2). In that study, stability
of the device and completeness of LAA occlusion was assessed in
formalin-fixed hearts. Formalin fixation, however, results in
tissue-shrinkage (5). Thus, complete LAA closure and device
stability may have been due to an artificial decrease of the LAA
size. Moreover, the mode of conservation may explain the
discrepancy between complete LAA occlusion in all dogs at the
postmortem study and the small leaks around the device in living
dogs immediately after the procedure and during follow-up.
6. Residual flow around the PLAATO device does not preclude
thrombus formation in the LAA. However, residual leaks in
case of thrombosis may be a new potential mechanism for
embolic events as in patients with incomplete surgical LAA
ligation (6). Therefore, it would be of great interest whether
patients with residual leaks experienced embolic events during
follow-up.
Before recommending PLAATO as a therapeutic option in
atrial fibrillation patients, more evidence about the long-term
effects of this procedure is required.
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REPLY
We thank Dr. Schneider and colleagues for their interest in our
study evaluating the effect of percutaneous left atrial appendage
transcatheter occlusion (PLAATO) on left atrial (LA) structure
and function (1). They list “several points of criticism” deserving of
comment.
Our study population is part of the cohort of patients in the
PLAATO feasibility trial. The report was based on all but one of
the U.S. patients who had completed six-month follow-up. Mea-
surements were available on a majority of patients (70% at six
months) (1). Data analysis showed no statistically significant
change in pulmonary venous flow or diastolic transmitral flow
following PLAATO. As described in our methods, LA size was
carefully measured at each time point. Though not included in the
final report, no significant change occurred compared to baseline.
Interesting endocrine functions of the left atrial appendage
(LAA) have been detailed by Stöllberger et al. (2). Human data on
atrial appendectomy are limited. To our knowledge no data
suggest detrimental clinical effects of LAA occlusion attributable to
a decrease in atrial natriuretic peptide. Yoshihara and colleagues
have indicated that exclusion of the LAA without exclusion of the
right atrial appendage has even less effect (3,4). Data concerning
endocrine LAA function were not part of the PLAATO trial and
remains an interesting area for research.
The circumflex coronary artery is variable in its relation to the
LAA. The artery runs in the atrioventricular groove and is
separated from the base of the LAA by atrial tissue. Oversizing of
an occlusion device could theoretically result in arterial compres-
sion. We used careful angiographic and echocardiographic sizing.
This and postimplant residual flow around PLAATO make
compromise of circumflex flow unlikely. Clinical data so far
support this.
Finally, Dr. Schneider and colleagues re-emphasize the point
that we made in our Discussion section. The impact of minimal
residual flow around the device on the occurrence of stroke has to
be assessed when the clinical follow-up is reported.
The aim of our study was to show no detrimental effect of
PLAATO on pulmonary vein flow and diastolic transmitral flow
in our patient population. Clinical follow-up data will be reported
for the entire PLAATO cohort. We agree that long-term data will
help answer many questions about the efficacy of PLAATO, but
we believe that percutaneous LAA occlusion will offer an impor-
tant option for selected patients with atrial fibrillation.
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Is Aspirin Resistance or
Female Gender Associated
With a High Incidence of
Myonecrosis After Nonurgent
Percutaneous Coronary Intervention?
We have with great interest read the report by Chen et al. (1)
published in the March 17 issue of the Journal. The prevalence of
aspirin resistance among patients with different manifestations of
atherosclerosis has been well established. However, studies ad-
dressing the clinical relevance of aspirin resistance are still lacking.
Therefore, studies as the one performed by Chen et al. (1) should
be appreciated.
To understand the clinical importance of the results presented,
however, we will take this opportunity to ask the investigators
whether the gender of the patients was included in the multivariate
analysis identifying independent predictors of creatine kinase-
myocardial band (CK-MB) elevation after percutaneous coronary
intervention (PCI)?
Female gender has been proposed to be a risk factor for
mortality and morbidity in relation to the performance of PCI
(2,3). This observation has been partly explained by older age,
more severe heart failure, an increased prevalence of co-morbidity,
and the presence of smaller coronary arteries in women compared
with men.
Chen et al. (1) showed that aspirin resistance is significantly
more prevalent in female (44.8%) than in male patients (19.7%).
This difference between genders in the occurrence of aspirin
resistance may in part account for the observed increased risk for
experiencing complications in relation to the PCI procedure (1).
Unfortunately, from the data presented it is not possible to decide
whether gender was included in the multivariate analysis. To put
the results of the study by Chen et al. (1) into an appropriate
clinical perspective, we would like the investigators to inform
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